Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Jun 12 | LGND | Ligand Pharmaceuticals INC | SSELL | 3,461 | $256.08 | $886.3K | -41.0% | Open the original filing on SEC.gov |
| Jun 12 | LGND | Ligand Pharmaceuticals INC | SSELL | 3,000 | $255.01 | $765K | -26.2% | Open the original filing on SEC.gov |
| Jun 12 | LGND | Ligand Pharmaceuticals INC | MEXER | 1,000 | $51.56 | $51.6K | +9.6% | Open the original filing on SEC.gov |
| Jun 12 | LGND | Ligand Pharmaceuticals INC | MEXER | 3,000 | $51.56 | $154.7K | +40.3% | Open the original filing on SEC.gov |
| Jun 5 | LGND | Ligand Pharmaceuticals INC | AGRANT◆ | 2,938 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | LGND | Ligand Pharmaceuticals INC | AGRANT | 836 | — | — | +12.7% | Open the original filing on SEC.gov |
| May 8 | ODTX | Odyssey Therapeutics, Inc. | PBUY | 1,000 | $20.00 | $20K | +1.6% | Open the original filing on SEC.gov |